세계의 환자 경험 기술 시장 : 제공 제품별, 기능별, 최종사용자별, 지역별 - 예측(-2030년)

The patient experience technology market is projected to reach USD 1.16 billion by 2030 from USD 0.66 billion in 2025, at a CAGR of 11.8%.

This growth is driven by increasing expectations for convenience and personalization (appointment scheduling, digital check-in, teletriage), regulatory pushes for patient access/interoperability, and rapid adoption of AI, ambient analytics, and conversational interfaces that automate administrative tasks and surface actionable insights from patient feedback and encounter data.

Vendors are increasingly integrating AI across patient experience platforms. For instance, in December 2023, Qualtrics announced a collaboration with Epic to integrate patient experience data directly into Epic's comprehensive health record (CHR) system. The partnership leverages Qualtrics' AI and natural language processing to fuse clinical and experiential data, enabling providers to deliver more personalized, empathetic care. The integration allows frontline staff to detect and act on patient sentiment, such as frustrations with scheduling, in real time, enhancing responsiveness and care outcomes.

Thus, such developments demonstrate that combining clinical and experiential data can drive more responsive and outcomes-focused patient care.

The cloud-based segment is expected to witness significant market share during the forecast period.

Based on the offering, the patient experience technology market is segmented into software/platform and services. The software segment is divided into on-premise, cloud-based, and hybrid. The cloud-based platform is expected to witness significant market growth during the forecast period due to its scalability, lower upfront costs, and ability to rapidly deploy updates. Healthcare providers increasingly favor cloud solutions for digital check-ins, telehealth triage, patient portals, and AI-driven personalization. Vendors such as Press Ganey, Qualtrics, and Epic are embedding cloud-native analytics, conversational AI, and ambient listening tools that improve flexibility and care access. In February 2025, Press Ganey partnered with Microsoft to develop generative AI-powered solutions that combine Press Ganey's dataset of over 7.6 billion patient encounters with Microsoft's AI, cloud, and ambient listening tools. This collaboration enables predictive analytics for patient safety, real-time actionable insights for providers, and secure data sharing via Azure, demonstrating that cloud-based PX platforms are driving personalization, efficiency, and improved patient experience.

Hence, such strategic collaborations underscore the growing role of cloud-based, AI-enabled patient experience platforms in delivering personalized, efficient, and data-driven care across healthcare settings.

The healthcare payers segment is expected to grow at a considerable CAGR during the forecast period.

By end user, the healthcare payers segment is expected to register the highest CAGR during the forecast period. Payers are increasingly investing in patient experience (PX) platforms to improve member engagement, streamline claims and administrative processes, and enhance overall satisfaction with health plan services. The growing emphasis on value-based care and outcomes-driven reimbursement models is prompting payers to leverage AI, analytics, and patient feedback tools to monitor service quality, predict member needs, and reduce preventable gaps in care.

Digital channels, such as member portals, teletriage, and automated communication tools, are being adopted to provide personalized, real-time support, improve adherence to preventive care, and strengthen patient loyalty. Additionally, regulatory mandates for interoperability and patient access, such as the US Cures Act and Europe's EHDS, are accelerating payer adoption of patient experience technologies. As a result, payers are emerging as a key growth driver in the market, reflecting their strategic focus on member experience and outcomes.

Europe is expected to lead the patient experience technology market in 2025.

During the forecast period, Europe is projected to hold a substantial share of the global patient experience technology market, driven by the widespread adoption of digital health technologies, rising demand for patient-centered care, and a robust regulatory environment that prioritizes data privacy and interoperability. A major trend is the shift toward personalized healthcare, with platforms and tools designed to tailor interventions to individual patient needs, enhancing adherence, satisfaction, and clinical outcomes. Governments, healthcare authorities, and public-private partnerships are playing a pivotal role in promoting patient involvement across the healthcare ecosystem. For instance, in March 2022, the European Health Initiative, a flagship public-private collaboration in life sciences with a USD 2.46 billion budget, established a Science & Innovation Panel that actively integrates patients in every stage of research, ensuring that healthcare solutions reflect real-world patient priorities.

In addition, the European Union's eHealth and Digital Decade initiatives are driving widespread adoption of electronic health records (EHRs), patient portals, and interoperable health systems, creating a fertile environment for patient engagement technologies. For instance, in July 2024, the European Commission released the Digital Decade 2024 study, highlighting progress toward universal access to electronic health records (EHRs) for EU citizens by 2030. The report noted that the EU27-average composite score for eHealth maturity increased from 72% to 79% in 2023, with 22 member states improving their performance.

Digital tools such as mobile health apps, telehealth platforms, AI-driven virtual assistants, and remote monitoring devices are increasingly being integrated into clinical workflows to improve communication, monitor treatment adherence, and support preventive care. Notable European vendors such as Doctrin (Sweden), Infermedica (Poland), and Cegedim (France) are actively expanding their patient engagement offerings, providing cloud-based, AI-enabled solutions that enable hospitals, clinics, and payers to enhance patient experience and operational efficiency.

These trends collectively signal that Europe will continue to be a leading region for patient engagement technology adoption, supported by ongoing government investments, regulatory incentives, and the increasing prioritization of patient empowerment in healthcare delivery.

The breakdown of primary participants is as mentioned below:

• By Company Type - Tier 1: 45%, Tier 2: 30%, and Tier 3: 25%
• By Designation - C Level: 42%, Director Level: 31%, and Others: 27%
• By Region - North America: 35%, Europe: 30%, Asia Pacific: 25%, Middle East & Africa: 5%, Latin America: 5%

Key Players

The key players functioning in the patient experience technology market include Press Ganey (US), National Research Corporation (NRC Health) (US), Medallia Inc. (US), Phreesia (US), NiCE (Israel), R1 (US), Epic Systems Corporation (US), IQVIA (US), Qualtrics (US), Relias LLC (US), GetWellNetwork (US), CipherHealth Inc. (US), Kyruus, Inc. (US), Twilio Inc. (US), Relatient (US), Alida (Canada), Certify Health (US), Avaamo (US), Luma Health Inc. (US), Solutionreach (US), and Salesforce, Inc. (US).

Research Coverage

The report analyzes the patient experience technology market. It aims to estimate the market size and future growth potential of various market segments based on component, use case, revenue model, end user, and region. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will enrich established firms and new entrants/smaller firms to gauge the market's pulse, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.

This report provides insights on:

• Analysis of key drivers: Drivers (rising demand for digital engagement platforms and personalized patient care, increasing adoption of telehealth, mobile health apps, and AI-powered analytics, government initiatives and funding for healthcare digital transformation, growing focus on improving patient satisfaction and long-term engagement, and expansion of cloud-based engagement platforms), Restraints (data privacy and cybersecurity concerns, high implementation and integration costs for healthcare providers, limited interoperability between patient engagement systems and existing EHRs), Opportunities (growth opportunities in emerging markets, adoption of AI-driven personalization and predictive analytics for patient care, strategic partnerships among technology platforms, pharma companies, and payers, and rising adoption of virtual reality and augmented reality) and Challenges (need to ensure accuracy and reliability of feedback data, rapid technological evolution) influencing the growth of the patient experience technology market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the patient experience technology market.
• Market Development: Comprehensive information on the lucrative emerging markets, by offerings, functions, end user, and region
• Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the patient experience technology market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the patient experience technology market such as Press Ganey (US), National Research Corporation (NRC Health) (US), Medallia Inc. (US), Phreesia (US), NiCE (Israel), R1 (US), Epic Systems Corporation (US), IQVIA (US), Qualtrics (US), Relias LLC (US), GetWellNetwork (US), CipherHealth Inc. (US), Kyruus, Inc. (US), Twilio Inc. (US), Relatient (US), Alida (Canada), Certify Health (US), Avaamo (US), Luma Health Inc. (US), Solutionreach (US), Salesforce, Inc. (US), Vital (US), NexHealth (US), Collectly, Inc. (US), Business Integrity Services (US), and Bamboo Health (US).

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE
  • 1.3.2 INCLUSIONS AND EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
• 1.4 CURRENCY CONSIDERED
• 1.5 STAKEHOLDERS
• 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 Breakdown of primary sources
• 2.2 RESEARCH METHODOLOGY
• 2.3 MARKET SIZE ESTIMATION
• 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
• 2.5 RESEARCH ASSUMPTIONS
  • 2.5.1 PARAMETRIC ASSUMPTIONS
  • 2.5.2 OVERALL STUDY ASSUMPTIONS
• 2.6 RESEARCH LIMITATIONS
  • 2.6.1 METHODOLOGY-RELATED LIMITATIONS
  • 2.6.2 SCOPE-RELATED LIMITATIONS
• 2.7 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 PATIENT EXPERIENCE TECHNOLOGY MARKET OVERVIEW
• 4.2 NORTH AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING AND REGION
• 4.3 PATIENT EXPERIENCE TECHNOLOGY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
• 4.4 PATIENT EXPERIENCE TECHNOLOGY MARKET: DEVELOPED VS. EMERGING ECONOMIES

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Rising demand for digital engagement platforms and personalized patient care
    • 5.2.1.2 Increasing adoption of telehealth, mobile health apps, and AI-powered analytics
    • 5.2.1.3 Government initiatives and funding for healthcare digital transformation
    • 5.2.1.4 Growing focus on improving patient satisfaction and long-term engagement
    • 5.2.1.5 Expansion of cloud-based engagement platforms
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Data privacy and cybersecurity concerns
    • 5.2.2.2 High implementation and integration costs for healthcare providers
    • 5.2.2.3 Limited interoperability between patient engagement systems and existing electronic health record systems
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Growth opportunities in emerging market
    • 5.2.3.2 Adoption of AI-driven personalization and predictive analytics for patient care
    • 5.2.3.3 Strategic partnerships among technology providers, pharma companies, and payers
    • 5.2.3.4 Rising adoption of virtual reality and augmented reality
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Need to ensure accuracy and reliability of feedback data
    • 5.2.4.2 Rapid technological evolution
• 5.3 INDUSTRY TRENDS
  • 5.3.1 INVESTMENTS IN PATIENT ENGAGEMENT AND EXPERIENCE PLATFORMS
  • 5.3.2 AI-DRIVEN PERSONALIZATION AND VIRTUAL ASSISTANTS
  • 5.3.3 CLOUD-BASED PLATFORMS AND OMNICHANNEL ACCESS
  • 5.3.4 TELEHEALTH AND HYBRID CARE MODELS
  • 5.3.5 IMMERSIVE TECHNOLOGIES FOR EDUCATION AND ADHERENCE
• 5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.5 PRICING ANALYSIS
  • 5.5.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER
  • 5.5.2 AVERAGE SELLING PRICE TREND, BY REGION
• 5.6 VALUE CHAIN ANALYSIS
• 5.7 ECOSYSTEM ANALYSIS
• 5.8 INVESTMENT AND FUNDING SCENARIO
• 5.9 TECHNOLOGY ANALYSIS
  • 5.9.1 KEY TECHNOLOGIES
    • 5.9.1.1 Voice-of-the-Patient (VoP) platforms
    • 5.9.1.2 Telehealth and virtual care platforms
    • 5.9.1.3 Patient portals and personal health records
    • 5.9.1.4 Remote Patient Monitoring (RPM)
  • 5.9.2 COMPLEMENTARY TECHNOLOGIES
    • 5.9.2.1 Interoperability/API and FHIR Infrastructure
    • 5.9.2.2 Patient identity management and authentication systems
  • 5.9.3 ADJACENT TECHNOLOGIES
    • 5.9.3.1 Clinical Decision Support Systems (CDSS)
    • 5.9.3.2 Population Health Management (PHM) platforms
    • 5.9.3.3 Patient engagement solutions
• 5.10 PATENT ANALYSIS
  • 5.10.1 PATENT PUBLICATION TRENDS
  • 5.10.2 JURISDICTION ANALYSIS
  • 5.10.3 MAJOR PATENTS IN PATIENT EXPERIENCE TECHNOLOGY MARKET
• 5.11 KEY CONFERENCES AND EVENTS, 2025-2027
• 5.12 CASE STUDY ANALYSIS
• 5.13 REGULATORY LANDSCAPE
  • 5.13.1 REGULATORY ANALYSIS
  • 5.13.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.14 PORTER'S FIVE FORCES ANALYSIS
  • 5.14.1 BARGAINING POWER OF SUPPLIERS
  • 5.14.2 BARGAINING POWER OF BUYERS
  • 5.14.3 THREAT OF NEW ENTRANTS
  • 5.14.4 THREAT OF SUBSTITUTES
  • 5.14.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.15 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.15.2 KEY BUYING CRITERIA
• 5.16 END-USER ANALYSIS
  • 5.16.1 UNMET NEEDS
  • 5.16.2 END-USER EXPECTATIONS
• 5.17 BUSINESS MODELS
• 5.18 IMPACT OF AI/GEN AI ON PATIENT EXPERIENCE TECHNOLOGY MARKET
  • 5.18.1 INTRODUCTION
  • 5.18.2 MARKET POTENTIAL OF AI IN PATIENT EXPERIENCE TECHNOLOGY
  • 5.18.3 AI USE CASES
  • 5.18.4 CASE STUDY ON IMPLEMENTATION OF AI/GEN AI
  • 5.18.5 INTERCONNECTED AND ADJACENT ECOSYSTEMS
    • 5.18.5.1 US healthcare technology market
    • 5.18.5.2 Patient engagement technology market
  • 5.18.6 USER READINESS AND IMPACT ASSESSMENT
    • 5.18.6.1 User readiness
      • 5.18.6.1.1 Hospitals & health systems
      • 5.18.6.1.2 Outpatient & ambulatory care centers
      • 5.18.6.1.3 Physician and group practices
      • 5.18.6.1.4 Long-term care and post-acute facilities
      • 5.18.6.1.5 Others
    • 5.18.6.2 Impact assessment
      • 5.18.6.2.1 Implementation
      • 5.18.6.2.2 Impact
• 5.19 IMPACT OF 2025 US TARIFFS ON PATIENT EXPERIENCE TECHNOLOGY MARKET
  • 5.19.1 INTRODUCTION
  • 5.19.2 KEY TARIFF RATES
  • 5.19.3 IMPACT ON COUNTRY/REGION
    • 5.19.3.1 US
    • 5.19.3.2 Europe
    • 5.19.3.3 Asia Pacific
  • 5.19.4 IMPACT ON END-USE INDUSTRIES
    • 5.19.4.1 Healthcare providers
    • 5.19.4.2 Healthcare payers
    • 5.19.4.3 Pharma & biotech companies
    • 5.19.4.4 Others

6 PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING

• 6.1 INTRODUCTION
• 6.2 SOFTWARE
  • 6.2.1 ON-PREMISE SOFTWARE
    • 6.2.1.1 Data sovereignty and seamless workflow ability to drive market
  • 6.2.2 CLOUD-BASED SOFTWARE
    • 6.2.2.1 Lower upfront costs and seamless interoperability to aid growth
  • 6.2.3 HYBRID SOFTWARE
    • 6.2.3.1 Ability to ensure maximum compliance and control to boost market
• 6.3 SERVICES
  • 6.3.1 MANAGED SERVICES
    • 6.3.1.1 Rising demand for operational efficiency and risk mitigation to encourage growth
  • 6.3.2 PROFESSIONAL SERVICES
    • 6.3.2.1 Need for continuous patient engagement to contribute to growth

7 PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION

• 7.1 INTRODUCTION
• 7.2 APPOINTMENT SCHEDULING
  • 7.2.1 GROWING TREND TOWARD OMNICHANNEL, INTELLIGENT PATIENT EXPERIENCE SOLUTIONS TO FUEL MARKET
• 7.3 PATIENT REGISTRATION
  • 7.3.1 NEED TO ENHANCE CLINICAL SAFETY AND OPERATIONAL PERFORMANCE TO AUGMENT GROWTH
• 7.4 VIRTUAL CARE
  • 7.4.1 EXPANDING REMOTE ACCESS AND CONTINUITY OF CARE TO AID GROWTH
• 7.5 PATIENT COMMUNICATION
  • 7.5.1 INCREASING LAUNCHES OF COMMUNICATION PLATFORMS TO BOLSTER GROWTH
• 7.6 BILLING
  • 7.6.1 INCREASING PUSH FOR TRANSPARENT AND AUTOMATED FINANCIAL WORKFLOWS TO SPUR GROWTH
• 7.7 FEEDBACK MANAGEMENT
  • 7.7.1 NEED FOR REAL-TIME INSIGHTS INTO PATIENT SATISFACTION, CARE QUALITY, AND SERVICE GAPS TO FACILITATE GROWTH
• 7.8 OTHER FUNCTIONS

8 PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER

• 8.1 INTRODUCTION
• 8.2 HEALTHCARE PROVIDERS
  • 8.2.1 HOSPITALS & HEALTH SYSTEMS
    • 8.2.1.1 Growing adoption of advanced digital and AI-driven platforms to bolster market
  • 8.2.2 OUTPATIENT & AMBULATORY CARE CENTERS
    • 8.2.2.1 Rising demand for preventive care, chronic disease management, and same-day procedures to promote growth
  • 8.2.3 PHYSICIANS & GROUP PRACTICES
    • 8.2.3.1 Increasing use of predictive analytics and remote monitoring tools to augment growth
  • 8.2.4 LONG-TERM CARE & POST-ACUTE FACILITIES
    • 8.2.4.1 Growing burden of aging population and chronic diseases to boost market
  • 8.2.5 OTHER HEALTHCARE PROVIDERS
• 8.3 HEALTHCARE PAYERS
  • 8.3.1 INCREASING ADVANCEMENTS IN ARTIFICIAL INTELLIGENCE AND VIRTUAL CARE MODELS TO FUEL MARKET
• 8.4 PHARMA & BIOTECH COMPANIES
  • 8.4.1 RISING INTEGRATION OF PATIENT EXPERIENCE TECHNOLOGY TO AID GROWTH
• 8.5 OTHER END USERS

9 PATIENT EXPERIENCE TECHNOLOGY MARKET, BY REGION

• 9.1 INTRODUCTION
• 9.2 NORTH AMERICA
  • 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 9.2.2 US
    • 9.2.2.1 Increasing adoption of digital solutions to contribute to growth
  • 9.2.3 CANADA
    • 9.2.3.1 Rising focus on healthcare delivery through digital innovation to expedite growth
• 9.3 EUROPE
  • 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 9.3.2 UK
    • 9.3.2.1 Growing focus on digital-first healthcare delivery and patient empowerment to drive market
  • 9.3.3 GERMANY
    • 9.3.3.1 Aging population and rising prevalence of chronic diseases to spur growth
  • 9.3.4 FRANCE
    • 9.3.4.1 Favorable policies and commitment to digital transformation to aid growth
  • 9.3.5 ITALY
    • 9.3.5.1 Expanding regulatory and reimbursement support to fuel market
  • 9.3.6 SPAIN
    • 9.3.6.1 Growing adoption of telemedicine to boost market
  • 9.3.7 REST OF EUROPE
• 9.4 ASIA PACIFIC
  • 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 9.4.2 JAPAN
    • 9.4.2.1 Rapidly growing elderly population to accelerate growth
  • 9.4.3 CHINA
    • 9.4.3.1 Widespread integration of healthcare services into super-apps to accelerate growth
  • 9.4.4 INDIA
    • 9.4.4.1 Increasing burden of non-communicable diseases and use of mobile-first platforms to favor growth
  • 9.4.5 SOUTH KOREA
    • 9.4.5.1 Booming medical tourism to speed up growth
  • 9.4.6 AUSTRALIA
    • 9.4.6.1 Matured healthcare system and digital infrastructure to promote growth
  • 9.4.7 REST OF ASIA PACIFIC
• 9.5 LATIN AMERICA
  • 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 9.5.2 BRAZIL
    • 9.5.2.1 Increase utilization of digital ecosystems to spur growth
  • 9.5.3 MEXICO
    • 9.5.3.1 Growing consumer-driven digital marketplaces to fuel market
  • 9.5.4 REST OF LATIN AMERICA
• 9.6 MIDDLE EAST & AFRICA
  • 9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 9.6.2 GCC COUNTRIES
    • 9.6.2.1 Rising healthcare investments to contribute to growth
    • 9.6.2.2 Saudi Arabia
      • 9.6.2.2.1 Digital health transformation programs to support growth
    • 9.6.2.3 UAE
      • 9.6.2.3.1 Rising patient expectations and entry of innovative regional platforms to aid growth
    • 9.6.2.4 Rest of GCC countries
  • 9.6.3 SOUTH AFRICA
    • 9.6.3.1 Growing smartphone penetration and supportive regulatory efforts to boost market
  • 9.6.4 REST OF MIDDLE EAST & AFRICA

10 COMPETITIVE LANDSCAPE

• 10.1 OVERVIEW
• 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PATIENT EXPERIENCE TECHNOLOGY MARKET
• 10.3 REVENUE ANALYSIS, 2020-2024
• 10.4 MARKET SHARE ANALYSIS, 2024
• 10.5 COMPANY VALUATION AND FINANCIAL METRICS
• 10.6 BRAND/SOFTWARE COMPARISON
• 10.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 10.7.1 STARS
  • 10.7.2 EMERGING LEADERS
  • 10.7.3 PERVASIVE PLAYERS
  • 10.7.4 PARTICIPANTS
  • 10.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 10.7.5.1 Company footprint
    • 10.7.5.2 Region footprint
    • 10.7.5.3 Offering footprint
    • 10.7.5.4 Function footprint
    • 10.7.5.5 End-user footprint
• 10.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
  • 10.8.1 PROGRESSIVE COMPANIES
  • 10.8.2 RESPONSIVE COMPANIES
  • 10.8.3 DYNAMIC COMPANIES
  • 10.8.4 STARTING BLOCKS
  • 10.8.5 COMPETITIVE BENCHMARKING OF STARTUPS/SMES, 2024
    • 10.8.5.1 Detailed list of key startups/SMEs
    • 10.8.5.2 Competitive benchmarking of key startups/SMEs
• 10.9 COMPETITIVE SCENARIO
  • 10.9.1 SOLUTION LAUNCHES AND ENHANCEMENTS
  • 10.9.2 DEALS
  • 10.9.3 EXPANSIONS

11 COMPANY PROFILES

• 11.1 KEY PLAYERS
  • 11.1.1 PRESS GANEY
    • 11.1.1.1 Business overview
    • 11.1.1.2 Solutions offered
    • 11.1.1.3 Recent developments
      • 11.1.1.3.1 Solution launches and enhancements
      • 11.1.1.3.2 Deals
    • 11.1.1.4 MnM view
      • 11.1.1.4.1 Right to win
      • 11.1.1.4.2 Strategic choices
      • 11.1.1.4.3 Weaknesses and competitive threats
  • 11.1.2 NATIONAL RESEARCH CORPORATION
    • 11.1.2.1 Business overview
    • 11.1.2.2 Solutions offered
    • 11.1.2.3 Recent developments
      • 11.1.2.3.1 Solution launches and enhancements
    • 11.1.2.4 MnM view
      • 11.1.2.4.1 Right to win
      • 11.1.2.4.2 Strategic choices
      • 11.1.2.4.3 Weaknesses and competitive threats
  • 11.1.3 MEDALLIA INC.
    • 11.1.3.1 Business overview
    • 11.1.3.2 Solutions offered
    • 11.1.3.3 Recent developments
      • 11.1.3.3.1 Solution launches and enhancements
      • 11.1.3.3.2 Deals
    • 11.1.3.4 MnM view
      • 11.1.3.4.1 Right to win
      • 11.1.3.4.2 Strategic choices
      • 11.1.3.4.3 Weaknesses and competitive threats
  • 11.1.4 PHREESIA
    • 11.1.4.1 Business overview
    • 11.1.4.2 Solutions offered
    • 11.1.4.3 Recent developments
      • 11.1.4.3.1 Solution launches and enhancements
      • 11.1.4.3.2 Deals
    • 11.1.4.4 MnM view
      • 11.1.4.4.1 Right to win
      • 11.1.4.4.2 Strategic choices
      • 11.1.4.4.3 Weaknesses and competitive threats
  • 11.1.5 NICE
    • 11.1.5.1 Business overview
    • 11.1.5.2 Solutions offered
    • 11.1.5.3 MnM view
      • 11.1.5.3.1 Right to win
      • 11.1.5.3.2 Strategic choices
      • 11.1.5.3.3 Weaknesses and competitive threats
  • 11.1.6 R1
    • 11.1.6.1 Business overview
    • 11.1.6.2 Solutions offered
    • 11.1.6.3 Recent developments
      • 11.1.6.3.1 Solution launches and enhancements
      • 11.1.6.3.2 Deals
  • 11.1.7 EPIC SYSTEMS CORPORATION
    • 11.1.7.1 Business overview
    • 11.1.7.2 Solutions offered
    • 11.1.7.3 Recent developments
      • 11.1.7.3.1 Solution launches and enhancements
      • 11.1.7.3.2 Deals
  • 11.1.8 IQVIA
    • 11.1.8.1 Business overview
    • 11.1.8.2 Solutions offered
    • 11.1.8.3 Recent developments
      • 11.1.8.3.1 Solution launches and enhancements
  • 11.1.9 QUALTRICS
    • 11.1.9.1 Business overview
    • 11.1.9.2 Solutions offered
    • 11.1.9.3 Recent developments
      • 11.1.9.3.1 Deals
      • 11.1.9.3.2 Expansions
      • 11.1.9.3.3 Other developments
  • 11.1.10 RELIAS LLC
    • 11.1.10.1 Business overview
    • 11.1.10.2 Solutions offered
    • 11.1.10.3 Recent developments
      • 11.1.10.3.1 Deals
  • 11.1.11 GETWELLNETWORK, INC.
    • 11.1.11.1 Business overview
    • 11.1.11.2 Solutions offered
    • 11.1.11.3 Recent developments
      • 11.1.11.3.1 Solution launches and enhancements
      • 11.1.11.3.2 Deals
  • 11.1.12 CIPHERHEALTH INC.
    • 11.1.12.1 Business overview
    • 11.1.12.2 Solutions offered
    • 11.1.12.3 Recent developments
      • 11.1.12.3.1 Solution launches and enhancements
      • 11.1.12.3.2 Deals
  • 11.1.13 KYRUUS, INC.
    • 11.1.13.1 Business overview
    • 11.1.13.2 Solutions offered
    • 11.1.13.3 Recent developments
      • 11.1.13.3.1 Solution launches and enhancements
      • 11.1.13.3.2 Deals
  • 11.1.14 RELATIENT
    • 11.1.14.1 Business overview
    • 11.1.14.2 Solutions offered
    • 11.1.14.3 Recent developments
      • 11.1.14.3.1 Solution launches and enhancements
  • 11.1.15 ALIDA
    • 11.1.15.1 Business overview
    • 11.1.15.2 Solutions offered
    • 11.1.15.3 Recent developments
      • 11.1.15.3.1 Other developments
  • 11.1.16 TWILIO INC.
    • 11.1.16.1 Business overview
    • 11.1.16.2 Solutions offered
    • 11.1.16.3 Recent developments
      • 11.1.16.3.1 Solution launches and enhancements
      • 11.1.16.3.2 Deals
  • 11.1.17 AVAAMO
    • 11.1.17.1 Business overview
    • 11.1.17.2 Solutions offered
    • 11.1.17.3 Recent developments
      • 11.1.17.3.1 Solution launches and enhancements
  • 11.1.18 CERTIFY HEALTH
    • 11.1.18.1 Business overview
    • 11.1.18.2 Solutions offered
    • 11.1.18.3 Recent developments
      • 11.1.18.3.1 Other developments
  • 11.1.19 LUMA HEALTH INC.
    • 11.1.19.1 Business overview
    • 11.1.19.2 Solutions offered
    • 11.1.19.3 Recent developments
      • 11.1.19.3.1 Solution launches and enhancements
      • 11.1.19.3.2 Deals
  • 11.1.20 SOLUTIONREACH
    • 11.1.20.1 Business overview
    • 11.1.20.2 Solutions offered
    • 11.1.20.3 Recent developments
      • 11.1.20.3.1 Solution launches and enhancements
  • 11.1.21 SALESFORCE, INC.
    • 11.1.21.1 Business overview
    • 11.1.21.2 Solutions offered
    • 11.1.21.3 Recent developments
      • 11.1.21.3.1 Solution launches and enhancements
• 11.2 OTHER PLAYERS
  • 11.2.1 VITAL
  • 11.2.2 NEXHEALTH
  • 11.2.3 COLLECTLY, INC.
  • 11.2.4 BUSINESS INTEGRITY SERVICES
  • 11.2.5 BAMBOO HEALTH

12 APPENDIX

• 12.1 DISCUSSION GUIDE
• 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 12.3 CUSTOMIZATION OPTIONS
• 12.4 RELATED REPORTS
• 12.5 AUTHOR DETAILS